Madejski Thomas J MD is categorized under Geriatric Physicians and Doctors in Albion, NY and active since 1996.
Madejski Thomas J MD was established in 1996, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Geriatric Physicians and Doctors business, which does work in the B2C market, and is classified as a Geriatric Physicians and Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Thomas Madejski at the company’s single location by writing to 243 South Main St # 105, Albion, New York NY 14411 or by phoning (585) 589-1322. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Madejski Thomas J MD |
| Contact Person: | Thomas Madejski |
| Address: | 243 South Main St # 105, Albion, New York 14411 |
| Phone Number: | (585) 589-1322 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Geriatric Physicians and Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Madejski Thomas J MD was started in 1996 to provide professional Geriatric Physicians and Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Thomas Madejski for inquiries that concern Madejski Thomas J MD by calling the company number (585) 589-1322, as your correspondence is most welcome. Additionally, the physical location of the single location of Madejski Thomas J MD can be found at the coordinates 43.2384,-78.19389 as well as the street address 243 South Main St # 105 in Albion, New York 14411.
For its online presence, you may visit Madejski Thomas J MD’s website at and engage with its social media outlets through on Twitter and on Facebook.